Researchers developed BioCompNet, a dual-sequence AI system that automates body composition measurement from MRI scans for improved cardiometabolic risk management.
Key Details
- 1BioCompNet uses a dual-channel 2D U-Net framework to process fat- and water-sequence MRI for abdominal and thigh segmentation.
- 2It quantifies 15 key body composition components automatically, including muscle, bone, and various fat compartments.
- 3Tested on 503 subjects internally and 30 cases externally, it achieved mean Dice scores of 0.938 (abdomen) and 0.936 (thigh) with strong physician agreement (ICC 0.881–0.999).
- 4Automated processing takes 0.12 minutes per case, compared to 128.8 minutes manually, enabling large-scale studies.
- 5Limitations include the need for broader validation across populations, refinement of clinical integration, and multicenter studies for further generalizability.
Why It Matters
This workflow represents a significant advance in scalable, automated MRI quantitative analysis, potentially enabling precise risk assessment and management for cardiometabolic diseases. It reduces the labor required for body composition measurements, supporting both large-cohort research and future clinical deployment.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.